Elena Maldi

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 4

Top Topics

Endoplasmic Reticulum Stress

Squamous Cell Carcinoma

Top Venues

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Carlos Sebastián, Christina Ferrer, Maria Serra, Jee-Eun Choi, Nadia Ducano, Alessia Mira, Manasvi S Shah, Sylwia A Stopka, Andrew J Perciaccante, Claudio Isella, Daniel Moya-Rull, Marianela Vara-Messler, Silvia Giordano, Elena Maldi, Niyati Desai, Diane E Capen, Enzo Medico, Murat Cetinbas, Ruslan I Sadreyev, Dennis Brown, Miguel N Rivera, Anna Sapino, David T Breault, Nathalie Y R Agar, Raul Mostoslavsky
A non-dividing cell population with high pyruvate dehydrogenase kinase activity regulates metabolic heterogeneity and tumorigenesis in the intestine. Nature communications 13 (1) (2022)
Laura Bizzozero, Margherita Pergolizzi, Davide Pascal, Elena Maldi, Giulia Villari, Jessica Erriquez, Marco Volante, Guido Serini, Caterina Marchiò, Federico Bussolino, Marco Arese
Tumoral Neuroligin 1 Promotes Cancer-Nerve Interactions and Synergizes with the Glial Cell Line-Derived Neurotrophic Factor. Cells 11 (2) (2022)
Danilo Galizia, Silvia Minei, Elena Maldi, Giovanna Chilà, Alessio Polidori, Marco Carlo Merlano
How Risk Factors Affect Head and Neck Squamous Cell Carcinoma (HNSCC) Tumor Immune Microenvironment (TIME): Their Influence on Immune Escape Mechanisms and Immunotherapy Strategy. Biomedicines 10 (10) (2022)
Ymera Pignochino, Giovanni Crisafulli, Giorgia Giordano, Alessandra Merlini, Enrico Berrino, Maria Laura Centomo, Giulia Chiabotto, Silvia Brusco, Marco Basiricò, Elena Maldi, Alberto Pisacane, Valeria Leuci, Dario Sangiolo, Lorenzo D'Ambrosio, Massimo Aglietta, Bernd Kasper, Alberto Bardelli, Giovanni Grignani
PARP1 Inhibitor and Trabectedin Combination Does Not Increase Tumor Mutational Burden in Advanced Sarcomas-A Preclinical and Translational Study. Cancers 13 (24) (2021)